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Aims Mitochondrial creatine kinase (MtCK) couples ATP production via oxidative phosphorylation to phosphocreatine in
the cytosol, which acts as a mobile energy store available for regeneration of ATP at times of high demand. We
hypothesized that elevating MtCK would be beneficial in ischaemia–reperfusion (I/R) injury.
....................................................................................................................................................................................................
Methods
and results
Mice were created over-expressing the sarcomeric MtCK gene with aMHC promoter at the Rosa26 locus (MtCK-
OE) and compared with wild-type (WT) littermates. MtCK activity was 27% higher than WT, with no change in
other CK isoenzymes or creatine levels. Electron microscopy confirmed normal mitochondrial cell density and
mitochondrial localization of transgenic protein. Respiration in isolated mitochondria was unaltered and metabolo-
mic analysis by 1 H-NMR suggests that cellular metabolism was not grossly affected by transgene expression. There
were no significant differences in cardiac structure or function under baseline conditions by cine-MRI or LV haemo-
dynamics. In Langendorff-perfused hearts subjected to 20 min ischaemia and 30 min reperfusion, MtCK-OE
exhibited less ischaemic contracture, and improved functional recovery (Rate pressure product 58% above WT;
P < 0.001). These hearts had reduced myocardial infarct size, which was confirmed in vivo: 55 ± 4% in WT vs.
29 ± 4% in MtCK-OE; P < 0.0001). Isolated cardiomyocytes from MtCK-OE hearts exhibited delayed opening of the
mitochondrial permeability transition pore (mPTP) compared to WT, which was confirmed by reduced mitochon-
drial swelling in response to calcium. There was no detectable change in the structural integrity of the mitochon-
drial membrane.
....................................................................................................................................................................................................
Conclusions Modest elevation of MtCK activity in the heart does not adversely affect cellular metabolism, mitochondrial or
in vivo cardiac function, but modifies mPTP opening to protect against I/R injury and improve functional recovery.
Our findings support MtCK as a prime therapeutic target in myocardial ischaemia.
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1. Introduction
The supply of cellular energy in the form of ATP is closely matched to
demand, yet ATP levels do not change in the normal heart even when
workload is increased suddenly. In the short-term, this is due to the cre-
atine kinase (CK) phosphagen system, which acts to buffer ATP levels
and signals for increased energy production.1 When demand is sustained,
this bridges the gap until rising levels of free calcium activate mitochon-
drial dehydrogenases to stimulate de novo ATP synthesis.2
The mitochondrial isoform of CK (MtCK) catalyses the transfer of a
phosphoryl group from ATP onto creatine to form phosphocreatine
(PCr) and ADP. Phosphocreatine is smaller and less polar than ATP, and
is therefore more readily diffusible and accumulates to higher levels
within the cell.3 It can be rapidly converted back to ATP under control
of cytosolic CK enzymes (Muscle and Brain isoforms, which are largely
bound to intracellular structures4–6) at times of high energy demand or
when energy supply is impaired, e.g. at the onset of ischaemia.7 The CK
system negates the need for ATP and ADP diffusion, which allows fine
control of the ATP/ADP ratio in different cellular compartments,
thereby optimizing reaction conditions and maintaining a high free-
energy of ATP hydrolysis.3,7,8
Striated muscles, such as heart, express ‘sarcomeric’ MtCK, with the
so-called ‘ubiquitous’ MtCK isoenzyme performing the equivalent role in
most other tissues.9 Under normal conditions, MtCK forms octamers
that exactly span the mitochondrial inter-membrane space. At the outer
membrane, Mt-CK forms a complex with the voltage-dependent anion
channel (VDAC), which regulates creatine/PCr exchange, and at the
inner membrane interacts with cardiolipin to allow close coupling with
the adenine nucleotide translocase (ANT), which regulates ADP/ATP
exchange.9–11 This functional unit links cytosolic energy requirements
with ATP production via oxidative phosphorylation,12 and furthermore,
these contact points also play a structural role to stabilize the mitochon-
drial membrane.10
Ischaemia represents an acute crisis in cellular energy provision, but
the challenge to cell survival also comes during reperfusion, when high
intracellular calcium, rising pH and generation of reactive oxygen species
(ROS) all act to stimulate opening of the mitochondrial permeability
transition pore (mPTP), which ultimately leads to cell death. This is
termed ischaemia/reperfusion (I/R) injury and represents a key thera-
peutic target to minimize myocardial damage following revascularization
procedures.13 MtCK is of particular interest in I/R injury since creatine
has been shown to reduce mPTP opening probability,14,15 but only when
MtCK is localized to the inter-mitochondrial membrane.14 Over-
expression of MtCK in murine liver has been shown to prevent mPTP
opening in response to calcium overload,16 and we have recently dem-
onstrated that MtCK over-expression in vitro protects against hypoxia/
reoxygenation induced cell death.17 Furthermore, double CK knockout
mice (mito- and M-CK) exhibit increased accumulation of calcium during
ischaemia and greater susceptibility to I/R injury,18 and MtCK activity
closely correlates with recovery of contractile function in post-
ischaemic myocardium.19
We therefore hypothesized that over-expression of MtCK would be
beneficial in the setting of I/R. Here, we describe a novel mouse model of
cardiac MtCK over-expression (MtCK-OE), with mitochondrial local-
ization and elevated MtCK activity. This was well tolerated with no effect
on mitochondrial cell density, respiration or in vivo cardiac function. We
show that MtCK-OE hearts have improved functional recovery and
reduced myocardial injury following I/R, and that isolated cardiomyo-
cytes and mitochondria are resistant to mPTP opening.
2. Methods
Detailed methods can be found in the Supplementary material online.
2.1 Animal husbandry
This investigation was approved by the University of Oxford Animal
Welfare and Ethical Review Board and conforms to the Animals
(Scientific Procedures) Act 1986 incorporating Directive 2010/63/EU of
the European Parliament. Mice were kept in specific pathogen-free cages,
12-h light–dark cycle, controlled temperature and humidity, and had
water and food ad libitum (Teklad global 16% rodent diet). All animals
were generated by hemizygous cross and compared to age and sex
matched littermates.
2.2 Generation and breeding of
transgenic mice
Mouse sarcomeric Ckmt2 with an HA-tag was cloned into a vector con-
taining the aMHC promoter and the machinery for PhiC31 integrase
mediated cassette exchange at the Rosa26 locus. The exchange vector
was co-electroporated with an expression cassette for PhiC31 into ac-
ceptor embryonic stem cells. Transgenic mice were generated by micro-
injecting embryonic stem cells into C57BL/6 J blastocysts, which were
implanted into pseudo-pregnant females to create chimeric founder
mice. Male chimeric founders were mated with wild-type C57BL/6 J fe-
males (Envigo, Huntingdon, UK). Homozygous transgenic (Tgþ/þ) mice
were generated by breeding F1 Tgþ/– males with F1 Tgþ/– females and
back-crossed onto C57BL/6 J genetic background for 10 generations.
Transgenic pups were identified by PCR from ear biopsies as detailed in
the Supplementary material online.
2.3 Tissue harvest and biochemistry
Mice were killed by cervical dislocation, tissue harvested, washed and
blotted in saline, snap frozen in liquid nitrogen, and stored at –80C until
used. Creatine was quantified by HPLC and then normalized to protein
content using the Lowry method in n = 10 left ventricular (LV) samples
per genotype (aged 9 weeks, 50% male). Citrate synthase activity
was measured spectrophotometrically in the same samples. Total CK ac-
tivity was measured in LV homogenates spectrophotometrically via a
coupled-enzyme assay in 12 week old mice (n = 25 WT, n = 18 Tgþ/-,
n = 15 Tgþ/þ). Using the same samples, individual CK isoenzymes were
separated by electrophoretic mobility on an agarose gel and a coupled-
enzyme assay performed in situ using the SAS-1 CK VIS-12 Isoenzyme kit
(Helena Biosciences). Absolute activities for each isoenzyme were calcu-
lated by multiplying relative isoenzyme activity (measured by densitom-
etry) with total CK activity. For octamer/dimer visualization, isolated
mitochondrial were pre-incubated with and without transition site ana-
logue complex (TSAC) to promote formation of dimers.20 We have pre-
viously verified the identity of MtCK bands using MtCK knockout tissue
and CK inhibitors.17
2.4 1H NMRmetabolomics
Crushed frozen heart samples from 14 week old female mice underwent
a standard dual-phase extraction protocol to separate aqueous and lipid
layers (n = 6 WT; n = 6 Tg). Samples were analysed on a Bruker 9.4 T
(400 MHz) spectrometer with bbo probe at 298 K. Detailed sample
preparation and scan parameters are included in the Supplementary ma-
terial online. TopSpin (version 2.1) software was used for data acquisi-
tion and for metabolite quantification. Peak areas were normalized to
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the internal standard peaks and metabolite concentrations quantified per
gram tissue wet weight. Data is shown as a fold change in mean metabol-
ite concentrations relative to wild-type control samples with a propa-
gated standard error (SEM) of the ratio. Unsupervised Principle
Component Analysis was performed in Matlab.21 Between group com-
parison was by Student’s t-test.
2.5 Electron microscopy
Hearts from male WT and MtCK-OE mice (30 weeks of age) were can-
nulated via the aorta, perfusion fixed, and prepared as described in
Supplementary material online. Sections were incubated with rat anti-
HA primary antibody, followed by an anti-rat conjugated to 5 nm gold,
before post-staining with uranyl acetate and Reynold’s lead citrate, and
imaging using a FEI Tecnai 12 TEM at 120 kV. Similar tissue preparation
with slight modifications was used to assess mitochondrial cell density in
n = 6 mouse hearts. Samples were blinded to the operator and 18–20
images were taken per heart at two magnifications, 890x, and 1900x,
within organized Z-line sections. Images were analysed in Image J (v1.50i,
NIH) using stereological methods.
2.6 Mitochondrial respiration
Respiration was assessed in isolated mitochondria from n = 8–9 male
mice per genotype (mean age 13 weeks). Basal and ADP-stimulated res-
piration was measured by a Clark-type electrode using the Mitocell
S200A Micro Respiratory system (Strathkelvin Instruments, Motherwell,
UK) with glutamate (5 mM), malate (2.5 mM), and Naþ-pyruvate (5 mM)
as substrates. See Supplementary material online for details of mitochon-
drial preparation.
2.7 Detergent-resistance measurements
(turbidity assay)
Isolated mitochondria from n = 6 female hearts per genotype (age
40 weeks) were placed in suspension at 0.5 mg protein/mL. Absorbance
was measured at 540 nm every 10 s for 30 min using a 96 well
plate reader (Kinetic microplate reader, Molecular Devices) with and
without addition of increasing concentrations of Triton X-100 (0–0.05%,
TX-100).22
2.8 Cine-MRI
Mice were anaesthetized with isoflurane 1.5–2% in oxygen with ECG
and respiration monitoring to ensure depth of anaesthesia and homeo-
thermic temperature control. Imaging was carried out on a 9.4 T
(400 MHz) MR system (Agilent Technologies) using a quadrature-driven
birdcage resonator (Rapid Biomedical) as previously described.15 Global
cardiac functional parameters were measured from double-gated, multi-
frame short-axis gradient-echo images covering the heart from the base
to apex.
2.9 Left ventricular haemodynamics
In vivo haemodynamics were performed in closed-chest freely breathing
mice under isoflurane general anaesthesia (1–1.5% in medical oxygen)
on a homeothermic blanket at 37C. A 1.4 F mikro-tip catheter (Millar,
Houston, USA) was advanced via the right carotid artery, across the aor-
tic valve, and into the LV. The jugular vein was cannulated with stretched
polyethylene tubing for administration of dobutamine at 16 ng/g body
weight/min to provide maximal b-adrenergic stimulation. Measurements
were taken after at least 15 min equilibration using a Powerlab 4SP
(ADInstruments, UK) and analysed using Chart Pro software (v5.5.5).
2.10 Ex vivomodel of ischaemia–
reperfusion
Female mice from n = 10 per genotype (age 21 weeks) were anesthe-
tized with sodium pentobarbital (55 mg/kg I.P.) and heparin (300 IU),
hearts were rapidly excised, cannulated, and perfused in Langendorff
mode. Hearts were allowed to equilibrate for 15 min, followed by 20 min
global no-flow ischaemia, and 30 min reperfusion with function meas-
ured throughout via intraventricular balloon. Hearts were perfused for a
further 30 min to allow sufficient wash-out of cellular dehydrogenases
before staining with triphenyltetrazolium chloride (TTC). Slices were
imaged, weighed and then analysed using Image J software to determine
infarct size as a percentage of LV.
2.11 In vivomodel of ischaemia–reperfusion
injury
Injury was induced in female mice aged 24 weeks under isoflurane an-
aesthesia and buprenorphine analgesia (1 mg/Kg subcutaneously) via
occlusion of the left anterior descending coronary artery for 45 min
as described previously.15 After 24 h of reperfusion, mice were
anaesthetized with intraperitoneal sodium pentobarbital (55 mg/kg) and
heparin (300 IU) and the hearts excised for histological analysis of area-
at-risk and infarct size using TTC staining as previously described.23
A total of 17/24 WT and 18/23 MtCK-OE mice completed the protocol
with two WT and one MtCK-OE excluded because the area-at-risk was
too small (<20%). This did not affect the outcome of this study.
2.12 mPTP assay in isolated
cardiomyocytes
Cardiomyocytes were isolated from n = 6 female mice per genotype
(aged 18–25 weeks) via gravity-driven retrograde perfusion of liberase in
Langendorff mode. Cells were plated onto pre-laminated dishes and left
at 37C overnight before commencing experiments. Cardiomyocytes
were loaded with tetramethylrhodamine methyl ester (TMRM), which
selectively localizes to the mitochondria, and visualized using confocal
fluorescence microscopy as previously described.24 Photo activation at
543 nm (5% power) generates reactive oxygen species, initiating mPTP
opening, and dequenching of the TMRM signal, which is observed as an
increase in fluorescence. The known mPTP inhibitor, 0.5mM cyclosporin
A, was used as a positive control.
2.13 Mitochondrial swelling assay
A calcium-induced mitochondria swelling assay was used to measure
mPTP opening in isolated cardiac mitochondria from n = 6 WT and n = 5
MtCK-OE female hearts.25 Change in optical density at 540 nm was
measured for 20 min using a spectrophotometer (Vmax, Molecular
Devices, California, USA), with cyclosporin A (1.0lM) used as a positive
control for inhibition of mPTP opening.
2.14 Statistical analysis
All experiments were analysed blind to genotype. Data are expressed as
mean± SEM unless otherwise stated. Statistical comparison between
two groups at a single time point was by Student’s t-test and between
three groups or more by one-way ANOVA. A two-way repeated meas-
ure (mixed model) ANOVA with Bonferroni correction for multiple
comparisons was used to statistically compare groups at multiple time
points. Differences were considered significant when P < 0.05.
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3. Results
3.1 Validation of transgenic model
Offspring produced by hemizygous breeding produced expected
Mendelian ratios (WT 72 pups, Tgþ/- 153, Tgþ/þ 68; Chi
squared = 0.686, two-tailed P = 0.71). Development was normal with no
significant difference in body weight growth curves over the 11 week
follow-up (see Supplementary material online, Figure S3). Expression of
transgenic mRNA was confined to the four chambers of the heart and
was absent in all other tissues samples (Figure 1A). A gene-dose effect
was demonstrated in left ventricle with homozygous mice showing twice
the mRNA expression levels of hemizygotes (Figure 1B). There was no
change in expression of endogenous mRNA (see Supplementary mater-
ial online, Figure S2C). Expression of transgenic protein was confirmed via
detection of the haemagglutinin tag in LV of transgenic animals only
(Figure 1C). MtCK commonly exists as octamers, but can also form less
active dimers.9 Mitochondrial fractions were incubated with increasing
concentrations of transition site analogue complex (TSAC), which
promotes the formation of dimers. In the absence of TSAC, all detect-
able MtCK was in the octameric state for both WT and Tg hearts, while
addition of TSAC resulted in dimer formation regardless of genotype
(Figure 1D). Transgenic mice exhibited a gene-dose dependent increase
in MtCK enzymatic activity, which was 27% higher in homozygote hearts
compared to WT (one-way ANOVA; P < 0.01). Myocardial creatine lev-
els and activity of the other CK isoenzymes were not significantly altered
(Figure 1E and F).
3.2 Mitochondrial localization
MtCK is located within the mitochondrial inter-membrane space, where
it also plays a structural role, we therefore sought to establish sub-
cellular localization and to rule-out potential adverse-effects on the
mitochondrial phenotype. Localization of transgenic protein to the mito-
chondria was confirmed using immunogold staining for the haemoggluti-
nin tag (Figure 2A). Scanning electron microscopy also allowed
quantification of mitochondrial cell density, which was not altered in
MtCK-OE hearts (Figure 2B and C). This was confirmed by unaltered
Figure 1 Model validation at mRNA, protein, and enzymatic activity levels. (A) Transgenic MtCK mRNA expression in a panel of tissues from MtCK over-
expressing mice indicating cardiac specificity for ventricles (LV, RV) and atria (LA, RA) (n = 2 M/2 F per tissue). (B) Quantitative RT-PCR for total MtCK tran-
script levels in LV illustrating gene dosing in wild-type (WT, n = 5 M/3 F), hemizygous (Tgþ/-, n = 9 M/4 F), and homozygous mice (Tgþ/þ, n = 6 M/8 F).
(C) Western blot showing detection of transgenic protein via haemagglutinin tag in LV tissue from Tgþ/þ (n = 4 male), but not WT mice. (D) Incubation of
mitochondrial fraction with transition site analogue complex (TSAC) to convert MtCK from octameric to dimeric form, suggesting that under normal condi-
tions all detectable MtCK is in the octameric form in both WT and Tg mice (representative blot from n = 3 repeats). (E) Activity of the mitochondrial CK iso-
enzyme is significantly elevated in a gene dose-dependent fashion, with no change in other CK isoforms (shown in order WT n = 25; Tgþ/- n = 28; Tgþ/þ
n = 15). (F) LV total creatine levels are not significantly altered by over-expression of MtCK (WT n = 10; Tgþ/þ n = 9). Data are represented as mean ± SEM.
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.citrate synthase activity, which is commonly used as a marker for
mitochondrial volume (Figure 2D). Respiration of isolated mitochondria
under basal and ADP-stimulated conditions was not modified by
MtCK over-expression (Figure 2E). Protein expression of closely
associated mitochondrial membrane proteins, ANT, VDAC, and
BCL-2 were not significantly altered (see Supplementary material online,
Figure S4).
3.3 1H NMRmetabolomics
A total of 23 aqueous and 24 lipid metabolites were reliably detected
in all samples, however, an unsupervised principal component ana-
lysis (PCA) did not detect separation between genotypes for either
aqueous or lipid phases (Figure 3A). The fold-change for individual me-
tabolites relative to WT hearts are shown in Figure 3B and C with ab-
solute concentrations provided in Supplementary material online,
Tables S2 and S3. Fold changes were small and only acetyl carnitine
showed a significant difference between genotypes, with higher levels
observed in MtCK-OE hearts (P = 0.043). This data suggests that
over-expression of Mt-CK does not grossly alter normal cellular
metabolism.
3.4 Baseline cardiac function
In vivo cardiac function was assessed under baseline conditions by cine-
MRI and left ventricular catheterization. There were no differences for
any parameter of morphology or function between wild-type, hemizy-
gous, and homozygous mice either at baseline or with maximal b-adren-
ergic stimulation with dobutamine (Table 1).
3.5 Ischaemia––reperfusion
All subsequent experiments compared homozygous MtCK-OE mice
with WT littermates.
Functional recovery: Cardiac function was measured in hearts perfused
in Langendorff mode for 15 min, followed by 20 min global no-flow is-
chaemia, and 30 min reperfusion (Figure 4). No significant differences
were observed during baseline equilibration, however, end-diastolic
pressure increased to higher levels in WT hearts during ischaemia and
remained higher throughout reperfusion, indicating that MtCK-OE
hearts were relatively protected from ischaemic contracture. MtCK-OE
hearts also had significantly better systolic function during reperfusion as
shown by higher developed pressures and rate pressure product. Heart
rates did not differ throughout.
Reperfusion injury: The extent of myocardial injury was measured in the
same Langendorff perfused hearts after a further 30 min reperfusion (ne-
cessary to wash-out dehydrogenases from dead cells for TTC staining23).
Mean infarct size (% of LV) was 35 ± 6 in WT and 21 ± 2 in MtCK-OE
hearts (P = 0.045), i.e. 40% less injury in transgenic mice (Figure 5A and B).
These findings were recapitulated in a separate cohort of mice in vivo
following 45 min of regional ischaemia and 24 h reperfusion. The per-
centage of LV exposed to ischaemia is defined as the area-at-risk, and
was not different between experimental groups, however, mean infarct
size (% of area-at-risk) was 55 ± 4 in WT and 29± 4 in MtCK-OE hearts,
i.e. 47% less injury in transgenic mice (Figure 5C and D).
3.6 Mechanistic role of mitochondria
Myocardial reperfusion injury is intrinsically linked to opening of the
mPTP, with subsequent loss of mitochondrial membrane potential and
Figure 2 Over-expression of MtCK does not alter mitochondrial phenotype. (A) Representative transmission electron microscopy images showing
immunogold staining for MtCK–HA was only detectable in LV sections from MtCK-OE mice and was localized to the mitochondria (black arrows; scale bar
200 nm). (B) Representative transmission electron microscopy images of male WT and MtCK-OE heart sections (890x magnification, scale bar 2lm), with
quantification of intracellular composition in (C), showing that mitochondrial cell density was unchanged (n = 6 male). (D) Citrate synthase activity as a
marker of mitochondrial volume was also unaffected (n = 5 M/5 F). (E) There were no differences in respiration from isolated mitochondria in the presence
of glutamate, malate and pyruvate (n = 8–9 male). Data are represented by mean ± SEM.
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..activation of cell death pathways.13 To determine the influence of MtCK
on this process, cardiomyocytes were isolated from WT and MtCK-OE
hearts, and the time to 50% mPTP opening (t50) was quantified using a
fluorescence-based assay (Figure 6A and B). As expected, pre-incubation
with Cyclosporin A (CsA), a known inhibitor of the mPTP, prolonged
t50, although this fell short of statistical significance in WT cells.
Nevertheless, in cells from MtCK-OE hearts, t50 was doubled, indicating
a significant delay in mPTP opening (P < 0.05). There was no additive
effect of pre-incubation with CsA (Figure 6C). To confirm these findings
we performed a mitochondrial swelling assay, whereby addition of cal-
cium causes mPTP opening and subsequent swelling is detected as a
change in optical density. WT mitochondria produced a large reduction
in optical density, which was prevented by pre-incubation with CsA con-
firming that swelling was due to mPTP opening. Mitochondria from
MtCK-OE hearts exhibited significantly less swelling compared to WT
and were comparable to CsA in ameliorating mPTP opening (Figure 6E).
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At the end of the assay, cytochrome c protein expression was measured
in the mitochondrial pellets by Western blot (Figure 6F). MtCK-OE mito-
chondria retained significantly more cytochrome c compared to WT,
which is consistent with reduced opening of the mPTP.
MtCK provides contact points between mitochondrial inner and
outer membranes, thereby providing structural support to maintain
mitochondrial integrity at times of stress.26 We therefore sought to de-
termine whether the modest elevation of MtCK in our model was suffi-
cient to benefit from this protective mechanism. Isolated mitochondria
from WT and MtCK-OE hearts were exposed to detergent (Triton X)
and the extent of membrane disruption was measured as an increase in
turbidity (and therefore absorbance) using spectrophotometry. The rate
of change in turbidity over a wide range of Triton X concentrations was
not modified by genotype (Figure 6D), suggesting that additional MtCK-
OE did not have a major effect on structural integrity.
4. Discussion
In this study, we created a novel murine model over-expressing the
mitochondrial isoform of creatine kinase. We confirmed that this did not
adversely affect mitochondrial cell density or function and that baseline
left ventricular function was normal. MtCK-OE hearts had less ischaemic
contracture and improved recovery of contractile function when com-
pared to WT littermates and this was associated with reduced myocar-
dial injury, both ex vivo and in vivo. In addition to improved energetics via
augmented MtCK activity, cardiomyocytes, and mitochondria from
over-expressing hearts demonstrated delayed opening of the mPTP.
Our transgenic model was specifically designed to obtain a modest
level of transgenic protein expression, since for MtCK to be active, it
must reside within the mitochondrial inter-membrane space, where cap-
acity for over-expression is likely to be limited.11,14 The transgene was
therefore inserted into a specific validated locus, Rosa26,27 which avoids
issues of random integration and excessive transgene copy number.28
We were careful to establish that transgenic protein localized to the
mitochondria in the native octameric state, and that mitochondrial cell
density and respiratory function were not impaired. The benign nature
of MtCK over-expression was confirmed by metabolomic analysis using
1 H-NMR, which suggests that normal cellular metabolism was not
altered by transgene expression. The only exception was higher acetyl
carnitine levels observed in MtCK-OE hearts, which could suggest an
abundance of fatty acid supply,29 although this was not evident in the lipid
phase metabolites. The lack of significant off-target metabolic effects was
mirrored by in vivo baseline cardiac function, which was shown by MRI
and LV haemodynamics to be completely normal.
Clearly, the modest levels of MtCK over-expression also represent a
limitation. With activity only 27% above WT levels, this is close to the
limits of detection for the protein and activity assays, which had to be
powered accordingly. However, this makes the robust level of cardio-
protection observed in both I/R models particularly remarkable and it is
possible that a less cautious approach could have even greater effect.
Furthermore, it is notable that MtCK activity falls by 30% in the failing
heart,30 which our data suggests is sufficient to potentially contribute
to the heightened mPTP sensitivity that has been observed in heart
failure.31
Our findings are in broad agreement with other published reports
that have sought to enhance phosphotransfer pathways in the setting of
I/R. Most notably, over-expression of the M-CK isoform has been shown
to improve recovery of contractile function in Langendorff perfused
hearts (n.b. the effect on myocardial injury has not been established).32
..............................................................................................................................................................................................................................
Table 1 In vivo indices of left ventricular structure and function
WT Tg1/2 Tg1/1
MRI n ¼ 7 (4M/3F) n ¼ 9 (5M/4F) n ¼ 9 (5M/4F)
End-diastolic volume (mL) 54 ± 15 57 ± 12 58 ± 13
End-systolic volume (mL) 24 ± 9 25 ± 8 26 ± 7
Ejection fraction (%) 55 ± 8 56 ± 5 55 ± 7
Stroke volume (mL) 30 ± 8 32 ± 5 33 ± 8
Heart rate (bpm) 396 ± 78 394 ± 60 462 ± 42
Cardiac index (mL/min/g) 0.52 ± 0.13 0.57 ± 0.10 0.64 ± 0.12
LV mass (mg/g) 3.3 ± 0.6 3.6 ± 0.5 3.5 ± 0.8
Haemodynamics n ¼ 10 (5M/5F) n ¼ 10 (5M/5F) n ¼ 10 (5M/5F)
LV end -systolic pressure (mmHg) 101 ± 6 105 ± 11 104 ± 9
LV end-diastolic pressure (mmHg) 6 ± 3 6 ± 3 6 ± 3
Heart rate (bpm) 444 ± 60 485 ± 91 464 ± 54
dP/dtmax (mmHg/s) 7631 ± 1305 8227 ± 1268 8030 ± 1804
dP/dtmin (mmHg/s) –4083 ± 533 –4344 ± 495 –4617 ± 915
Tau (ms) 14.4 ± 5.3 17.6 ± 10.6 14.4 ± 5.8
Stimulated dP/dtmax (mmHg/s) 12 006 ± 3014 12 104 ± 1765 10 541 ± 2553
Stimulated Heart rate (bpm) 556 ± 60 601 ± 61 570 ± 65
Aortic systolic pressure (mmHg) 96 ± 10 95 ± 15 94 ± 4
Aortic diastolic pressure (mmHg) 65 ± 9 65 ± 16 64 ± 5
Mean aortic pressure (mmHg) 80 ± 9 79 ± 15 78 ± 5
Wild-type (WT), hemizygous (Tgþ/-), and homozygous (Tgþ/þ) mice over-expressing Mt-CK. Stimulated dP/dt denotes value obtained during maximal stimulation with dobut-
amine 16 ng/g BWt/min. Data is mean ± SD. No statistically significant differences were observed when transgenic groups were compared with WT using one-way ANOVA fol-
lowed by Dunnett’s multiple comparison test.
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..It is not a foregone conclusion that Mt-CK would also be protective. The
CK system is highly compartmentalized with the M-CK isoenzyme exist-
ing as a cytosolic dimer localized to the myofibrils, where it catalyses the
reverse reaction to regenerate ATP from PCr.33 Our study shows that a
mitochondrial CK isoenzyme that is functionally coupled to oxidative
phosphorylation improves functional recovery post-ischaemia and we
present the first evidence for CK protection against myocardial injury,
including a demonstration of in vivo relevance.
We have previously shown that moderately elevating myocardial cre-
atine levels by over-expression of the creatine transporter (CrT-OE),
likewise, improves energetic and functional recovery ex vivo and reduces
myocardial injury in vivo.15 Notably, this approach also offered cardio-
protection in the presence of co-morbidities such as old age and cardiac
hypertrophy.34
In both M-CK and CrT over-expression models,31P-NMR was used
to measure high-energy phosphates during I/R.15,32 M-CK-OE mice had
normal PCr at baseline, whereas PCr was elevated in CrT-OE, but re-
gardless, ATP levels were not modified either at baseline or in the
response during I/R. Nevertheless, in both strains, recovery of PCr dur-
ing reperfusion was particularly rapid, attaining higher levels than in wild-
type, which could provide energetically favourable conditions for a rapid
return to ionic homeostasis, thereby reducing reperfusion injury.15,32
It is a limitation of the current study that we do not have the
equivalent31P-NMR data for MtCK-OE mice, which means we can only
speculate on the likely protective contribution of altered high-energy
phosphates or intracellular pH. Likewise, it is a limitation that we have
not measured adenine nucleotides or their breakdown products since it
is possible that elevated MtCK activity could modify the adenylate energy
charge or cellular adenosine release under ischaemic conditions.
Multiple lines of enquiry have implicated MtCK as a modulator of
mPTP opening, either directly, or by influencing proteins to which it is
functionally coupled, e.g. ANT and VDAC. For example, over-expres-
sion of the ubiquitous isoform of MtCK in mouse hepatocytes protected
against mPTP opening in response to calcium overload,16 but only in the
octameric form and in the presence of creatine,14 implicating a role for
functional channelling of ADP via the ANT.11 It should be noted that
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Figure 4 Over-expression of MtCK improves functional recovery following ischaemia–reperfusion ex vivo. Hearts were perfused for 15 min at baseline,
20 min no-flow global ischaemia, and 30 min reperfusion. (A) Heart rate; (B) LV systolic pressure; (C) LV end-diastolic pressure; (D) developed pressure; and
(E) rate pressure product, RPP. Data are from n = 10 females per genotype and represent mean ± SEM. Between group comparisons by two-way repeated
measures ANOVA with Bonferroni post-hoc test. * denotes P < 0.05, **P < 0.01, and ***P < 0.001.
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..hepatocytes do not normally express any CK isoforms,16 so over-ex-
pression may result in an exaggerated response. Our study is the first to
confirm delayed mPTP opening with MtCK over-expression in isolated
cardiomyocytes and therefore brings physiological relevance to these
earlier observations.
The influence of MtCK on the mPTP may be independent of any
positive effect on high-energy phosphate metabolism since our assay
uses a burst of reactive oxygen species (ROS) to stimulate pore
opening, thereby modelling reperfusion, but not the energy deficit
inherent with ischaemia. Furthermore, it is likely that MtCK directly
influences classical mPTP pathways since there was no additive effect
of pre-incubation with the cyclophilin D inhibitor, cyclosporin A.
However, we cannot rule out an effect of MtCK on regulators
of apoptosis such as bcl-2 and bax, which are located on the
mitochondrial outer membrane and may modify sensitivity to
mPTP opening.35,36
MtCK has been shown to reduce ROS formation under hypergly-
caemic conditions by maintaining ADP cycling and thereby effective cou-
pling with oxidative phosphorylation.37 A similar effect has been
described for myocardial ANT over-expression, which was associated
with reduced infarct size following myocardial infarction.38 In addition,
MtCK is known to be highly sensitive to inactivation by ROS and in par-
ticular peroxynitrite that forms during ischaemia.39 In the ischaemic
heart, this was shown to promote MtCK transition from octamer to
dimer, which contributes to the energetic deficit.40 Simply increasing the
quantity of functional MtCK octamers may therefore have a protective
role, i.e. protection in numbers.
The final mechanism for consideration relates to the structural role of
MtCK in maintaining contact sites between the inner and outer mito-
chondrial membranes, thereby providing mechanical stability.26,41
Mitochondrial-bound hexokinase 2 (HK2) stabilizes these contact sites
via interactions with VDAC and ANT,42 such that, dissociation of HK2 is
associated with increased I/R injury.43 Preventing this dissociation and
thereby preserving contact sites may underpin the cardio-protective ef-
fects of ischaemic preconditioning.44,45 Over-expression of ubiquitous
MtCK in the liver has been shown to increase the number of contact
sites three-fold, conferring relative resistance to rupture when mito-
chondria were exposed to detergent.22 However, employing the same
assay in mitochondria from our MtCK-OE mice, we were unable to de-
tect this effect, perhaps unsurprising, given the high baseline levels of
MtCK in heart and the modest level of transgenic protein expression in
our model. Any contribution from increased contact points is therefore
likely to be minor.
It remains to be seen whether augmenting both enzyme and substrate
will have a synergistic effect, but this was behind our decision to create a
simple constitutively active model. This will allow us to easily generation
double transgenics by crossing MtCK-OE with existing mice that over-
express the creatine transporter. We postulate that a double transgenic
may rescue the adverse phenotype associated with very high levels of
creatine, where CK activity may be limiting in maintaining the optimal
ratio of phosphocreatine-to-creatine.46
In conclusion, the potential for MtCK to protect against cellular stress
has long been recognized, but the proof-of-principle studies at the organ
and whole organism level have been missing. Our study provides the first
Figure 5 Over-expression of MtCK reduces myocardial injury following ischaemia–reperfusion ex vivo and in vivo. At the end of experiments shown in
Figure 4, perfused hearts were sliced and stained with triphenyltetrazolium chloride (TTC), which stains viable tissue red, while necrotic tissue appears pale
in colour. (A) Shows representative sections spanning apex to base for WT and MtCK-OE hearts, with quantification of infarct size shown in (B) and com-
parison by two-tailed Welch’s t-test to reflect unequal variances. The analogous experiment was also performed in vivo with 45 min regional ischaemia and
24 h reperfusion. (C) Shows representative LV histological sections spanning apex to base. Myocardium that did not experience ischaemia appears blue, all
other areas constitute the area-at-risk (AAR), while within this, necrotic tissue (infarct) appears pale or white. Quantification in (D) shows no difference in
AAR, but a greatly reduced infarct size in hearts from MtCK-OE mice compared to WT mice using a two-tailed Student’s t-test (n = 17 and n = 15 females,
respectively). Data are represented as mean ± SEM.
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Figure 6 Over-expression of MtCK delays opening of the mitochondrial permeability transition pore (mPTP) in vitro. (A) Example images of primary cardi-
omyocytes from mouse heart loaded with fluorescent dye tetramethylrhodamine methyl ester (TMRM). Under baseline conditions TMRM is localized to
mitochondria (i), but laser stimulation triggers generation of reactive oxygen species and subsequent mPTP opening as a function of time. This is observed as
increased fluorescence due to redistribution of TMRM from mitochondria to the cytosol (ii) and quantified as time to 50% of maximum fluorescence (t50),
which precedes cell death (iii). (B) Representative traces of fluorescence against time for cardiomyocytes derived from wild-type (WT) and MtCK over-
expressing hearts, with and without the addition of 0.5lM cyclosporin A (CsA), a known mPTP inhibitor. (C) The mean t50 values from n = 6 individual cardi-
omyocyte isolations per group demonstrate delayed mPTP opening in cells from MtCK-OE compared to WT (* P < 0.05), without an additive effect of CsA.
(D) The turbidity of a suspension of isolated mitochondria changes with addition of detergent (Triton X), with the rate of change, measured by absorbance,
reflecting the structural integrity of the membrane. There was no difference in the rate of change over a range of Triton-X concentrations between mito-
chondria from WT and MtCK-OE hearts (n = 6 females per genotype). (E) Isolated mitochondria from WT hearts exhibit mitochondrial swelling after add-
ition of 600lM CaCl2, observed as a reduction in optical density over time. Swelling was significantly reduced in the presence of CsA indicating involvement
of the mPTP (n = 6). Over-expression of MtCK was as effective as CsA alone in preventing swelling, with a small additive effect of CsA, which did not reach
statistical significance (n = 5). The left ventricle from two male mice were used per experiment and analysis was by two-way ANOVA (P = 0.02 for effect of
genotype) with Tukey post-hoc test for multiple comparisons. (F) At the end of the swelling assay, protein expression of cytochrome c was measured by
Western blot and normalized to VDAC. Comparison by unpaired two-way Student’s t-test showed significantly more cytochrome c was retained in the
MtCK-OE mitochondria consistent with reduced opening of mPTP. Data in all graphs are represented as mean± SEM.
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.
evidence that even a very modest increase in MtCK activity improves
post-ischaemic recovery of contractile function in the intact heart, and
protects against myocardial injury in vivo. This adds to the mounting
evidence that augmentation of the CK system is beneficial in I/R and rep-
resents a viable therapeutic target. Future work will focus on the identifi-
cation of small molecules that increase creatine kinase activity for the
translation of these findings.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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